相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Emergence of Indigenous Artemisinin-Resistant Plasmodium falciparum in Africa
Feng Lu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Independent Emergence of the Plasmodium falciparum Kelch Propeller Domain Mutant Allele C580Y in Guyana
Stella M. Chenet et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Efficacy and Safety of Pyronaridine-Artesunate for Treatment of Uncomplicated Plasmodium falciparum Malaria in Western Cambodia
Rithea Leang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial
Bronner P. Goncalves et al.
BMC MEDICINE (2016)
Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers
James S. McCarthy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial
Issaka Sagara et al.
LANCET INFECTIOUS DISEASES (2016)
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
Aung Pyae Phyo et al.
LANCET INFECTIOUS DISEASES (2016)
Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial
Alassane Dicko et al.
LANCET INFECTIOUS DISEASES (2016)
The Community As the Patient in Malaria-Endemic Areas: Preempting Drug Resistance with Multiple First-Line Therapies
Maciej F. Boni et al.
PLOS MEDICINE (2016)
The Gametocytocidal Efficacy of Different Single Doses of Primaquine with Dihydroartemisinin-piperaquine in Asymptomatic Parasite Carriers in The Gambia: A Randomized Controlled Trial
Joseph Okebe et al.
EBIOMEDICINE (2016)
Continued Sensitivity of Plasmodium falciparum to Artemisinin in Guyana, With Absence of Kelch Propeller Domain Mutant Alleles
Reyaud Rahman et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
Antimalarial drug resistance in Africa: key lessons for the future
Shannon Takala-Harrison et al.
MALARIA: ADVANCES IN PATHOPHYSIOLOGY, BIOLOGY, AND DRUG DEVELOPMENT (2015)
Malaria and the Millennium Development Goals
Stephen Owens
ARCHIVES OF DISEASE IN CHILDHOOD (2015)
Supporting malaria elimination with 21st century antimalarial agent drug discovery
Thierry T. Diagana
DRUG DISCOVERY TODAY (2015)
Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker
Kyaw M. Tun et al.
LANCET INFECTIOUS DISEASES (2015)
An assessment of the supply, programmatic use, and regulatory issues of single low-dose primaquine as a Plasmodium falciparum gametocytocide for sub-Saharan Africa
Ingrid Chen et al.
MALARIA JOURNAL (2015)
Malaria medicines: a glass half full?
Timothy N. C. Wells et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
A Brief History of Qinghaosu
Nicholas J. White et al.
TRENDS IN PARASITOLOGY (2015)
Optimum population-level use of artemisinin combination therapies: a modelling study
Tran Dang Nguyen et al.
LANCET GLOBAL HEALTH (2015)
Pharmacokinetic Interactions between Primaquine and Pyronaridine-Artesunate in Healthy Adult Thai Subjects
Podjanee Jittamala et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
Borimas Hanboonkunupakarn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Single low-dose primaquine to reduce malaria transmission
Richard W. Steketee et al.
LANCET INFECTIOUS DISEASES (2014)
Single dose primaquine for clearance of Plasmodium falaparum gametocytes in children with uncomplicated malaria in Uganda: a randomised, controlled, double-blind, dose-ranging trial
Alice C. Eziefula et al.
LANCET INFECTIOUS DISEASES (2014)
Were medicine quality and pharmaceutical management contributing factors in diminishing artemisinin efficacy in Guyana and Suriname?
Victor S. Pribluda et al.
MALARIA JOURNAL (2014)
Primaquine: the risks and the benefits
Elizabeth A. Ashley et al.
MALARIA JOURNAL (2014)
A molecular marker of artemisinin-resistant Plasmodium falciparum malaria
Frederic Ariey et al.
NATURE (2014)
The Origins of Antimalarial-Drug Resistance
Randall M. Packard
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Spiroindolone KAE609 for Falciparum and Vivax Malaria
Nicholas J. White et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance
C. Wongsrichanalai et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Artemisinin resistance or artemisinin-based combination therapy resistance?
Chansuda Wongsrichanalai
LANCET INFECTIOUS DISEASES (2013)
Safety and efficacy of pyronaridine-artesunate in uncomplicated acute malaria: an integrated analysis of individual patient data from six randomized clinical trials
Stephan Duparc et al.
MALARIA JOURNAL (2013)
Designing the next generation of medicines for malaria control and eradication
Jeremy N. Burrows et al.
MALARIA JOURNAL (2013)
Targeting Plasmodium PI(4)K to eliminate malaria
Case W. McNamara et al.
NATURE (2013)
Antimalarial drug discovery - approaches and progress towards new medicines
Erika L. Flannery et al.
NATURE REVIEWS MICROBIOLOGY (2013)
Evidence of an increased incidence of day 3 parasitaemia in Suriname: an indicator of the emerging resistance of Plasmodium falciparum to artemether
Stephen G. S. Vreden et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2013)
Arterolane Maleate Plus Piperaquine Phosphate for Treatment of Uncomplicated Plasmodium falciparum Malaria: A Comparative, Multicenter, Randomized Clinical Trial
Neena Valecha et al.
CLINICAL INFECTIOUS DISEASES (2012)
Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents
Advait Nagle et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach
Tiago Antao et al.
MALARIA JOURNAL (2012)
Pyronaridine-artesunate granules versus artemether-lumefantrine crushed tablets in children with Plasmodium falciparum malaria: a randomized controlled trial
Kassoum Kayentao et al.
MALARIA JOURNAL (2012)
Pyronaridine-Artesunate versus Mefloquine plus Artesunate for Malaria
Ronnatrai Rueangweerayut et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Piperaquine Resistance Is Associated with a Copy Number Variation on Chromosome 5 in Drug-Pressured Plasmodium falciparum Parasites
Richard T. Eastman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Artemisinin: Discovery from the Chinese Herbal Garden
Louis H. Miller et al.
CELL (2011)
Imidazolopiperazines: Hit to Lead Optimization of New Antimalarial Agents
Tao Wu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
A Research Agenda to Underpin Malaria Eradication
Pedro L. Alonso et al.
PLOS MEDICINE (2011)
Efficacy and safety of a fixed-dose oral combination of pyronaridine-artesunate compared with artemether-lumefantrine in children and adults with uncomplicated Plasmodium falciparum malaria: a randomised non-inferiority trial
Antoinette K. Tshefu et al.
LANCET (2010)
Changes in the burden of malaria in sub-Saharan Africa
Wendy Prudhomme O'Meara et al.
LANCET INFECTIOUS DISEASES (2010)
Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty
David L. Smith et al.
MALARIA JOURNAL (2010)
A brief history of malaria chemotherapy
A. R. Butler et al.
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH (2010)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Fixed-dose pyronaridine-artesunate combination for treatment of uncomplicated falciparum malaria in pediatric patients in Gabon
Michael Ramharter et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Benefits of using multiple first-line therapies against malaria
Maciej F. Boni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Qinghaosu (Artemisinin): The price of success
N. J. White
SCIENCE (2008)
Malaria chemotherapeutics part 1: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development
Martin Schlitzer
CHEMMEDCHEM (2007)
Antimalarial activity of a synthetic endoperoxide (RBx-11160/OZ277) against Plasmodium falciparum isolates from gabon
A Kreidenweiss et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
The quest for quinine: Those who won the battles and those who won the war
TS Kaufman et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Intercontinental spread of pyrimethamine-resistant malaria
C Roper et al.
SCIENCE (2004)
Identification of an antimalarial synthetic trioxolane drug development candidate
JL Vennerstrom et al.
NATURE (2004)
Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum
JC Wootton et al.
NATURE (2002)
Epidemiology of drug-resistant malaria
C Wongsrichanalai et al.
LANCET INFECTIOUS DISEASES (2002)
Patterns of Plasmodium falciparum drug resistance in nonimmune travellers to Africa
T Jelinek et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2001)
Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site
M Korsinczky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon Region of Brazil
KF Vasconcelos et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2000)
分享论文
